150 Participants Needed

Effects of Therapeutic Mobile Game on Anxiety

TA
NG
Overseen ByNayan Ghosh
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Hunter College of City University of New York

Trial Summary

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What is the purpose of this trial?

This trial tests a mobile app called ABM-01 to help adults aged 22-65 with Social Anxiety Disorder. Participants use the app regularly for a period to manage and reduce their social anxiety symptoms.

Research Team

TA

Tracy A Dennis-Tiwary, PhD

Principal Investigator

City University of New York, School of Public Health

Eligibility Criteria

Inclusion Criteria

Adults 22-65 at the time of screening
You have been diagnosed with Social Anxiety Disorder according to the DSM-5 guidelines.
Access to and willingness to use computer equipment/smartphone compatible with the product platform over a functional network for the study duration
See 1 more

Exclusion Criteria

You have a high risk of attempting suicide or have tried to commit suicide within the past two years.
Currently pregnant or planning to become pregnant during the treatment period
You have a serious problem with using drugs or alcohol.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Session

Participants complete baseline assessments before starting treatment

1 day
1 visit (virtual)

30-Day Treatment Phase

Participants use the digital therapeutic ABM-01 and complete assessments remotely

4 weeks
Remote assessments

Post-Treatment Session

Participants complete assessments after the treatment phase

1 day
1 visit (virtual)

6-Month Follow-Up Session

Participants are monitored for safety and effectiveness 6 months after treatment

1 day
1 visit (virtual)

12-Month Follow-Up Session

Participants are monitored for safety and effectiveness 12 months after treatment

1 day
1 visit (virtual)

Treatment Details

Interventions

  • ABM-01
  • Digital Control
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental groupExperimental Treatment1 Intervention
Participants receive active ABM-01 for the study
Group II: Placebo ControlPlacebo Group1 Intervention
Participants receive a digital control for the study

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hunter College of City University of New York

Lead Sponsor

Trials
43
Recruited
10,000+

Wise Therapeutics Inc.

Collaborator

Trials
1
Recruited
150+

Arcade Therapeutics Inc.

Collaborator

Trials
1
Recruited
150+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security